Graft-versus-host disease: suppression by statins.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 18989280.
- Also identified by DOI 10.1038/nm1108-1155.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Two big challenges of transplantation biology are controlling the reaction of the graft to the host after hematopoietic stem cell transplantation and preventing rejection of donor organs by the host. Raewyn Broady and Megan K. Levings discuss the first challenge, examining studies suggesting that statins might be helpful to control graft-versus-host disease. Kathryn Wood tackles the second challenge in the context of the 'Edmonton protocol', a procedure that can restore the ability to control blood glucose in people with type 1 diabetes--but only in the short term.
Medical subject headings
- Graft vs Host Disease
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Immunosuppressive Agents